Medivate Partners is a private equity general partner firm headquartered in Seoul, South Korea.
Sillajen, a South Korea-based global oncolytic immunotherapeutic company, raised $12m in funding from Medivate Partners.
Read more news concerning Medivate Partners
A sampling of Medivate Partners portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?